ABSTRACT
BACKGROUND: In 2021, the American College of Medical Genetics and Genomics (ACMG) recommended reporting actionable genotypes in 73 genes associated with diseases for which preventive or therapeutic measures are available. Evaluations of the association of actionable genotypes in these genes with life span are currently lacking. METHODS: We assessed the prevalence of coding and splice variants in genes on the ACMG Secondary Findings, version 3.0 (ACMG SF v3.0), list in the genomes of 57,933 Icelanders. We assigned pathogenicity to all reviewed variants using reported evidence in the ClinVar database, the frequency of variants, and their associations with disease to create a manually curated set of actionable genotypes (variants). We assessed the relationship between these genotypes and life span and further examined the specific causes of death among carriers. RESULTS: Through manual curation of 4405 sequence variants in the ACMG SF v3.0 genes, we identified 235 actionable genotypes in 53 genes. Of the 57,933 participants, 2306 (4.0%) carried at least one actionable genotype. We found shorter median survival among persons carrying actionable genotypes than among noncarriers. Specifically, we found that carrying an actionable genotype in a cancer gene was associated with survival that was 3 years shorter than that among noncarriers, with causes of death among carriers attributed primarily to cancer-related conditions. Furthermore, we found evidence of association between carrying an actionable genotype in certain genes in the cardiovascular disease group and a reduced life span. CONCLUSIONS: On the basis of the ACMG SF v3.0 guidelines, we found that approximately 1 in 25 Icelanders carried an actionable genotype and that carrying such a genotype was associated with a reduced life span. (Funded by deCODE Genetics-Amgen.).
Subject(s)
Disease , Genomics , Longevity , Humans , Alleles , Genetic Testing , Genetic Variation , Genotype , Iceland/epidemiology , Longevity/genetics , Disease/genetics , Cardiovascular Diseases/genetics , Neoplasms/geneticsSubject(s)
Alzheimer Disease , Membrane Glycoproteins , Receptors, Immunologic , Aged , Female , Humans , Male , Alzheimer Disease/ethnology , Alzheimer Disease/genetics , Alzheimer Disease/metabolism , Apolipoproteins E/metabolism , Cholesterol, LDL/metabolism , Clusterin/metabolism , Genetic Predisposition to Disease/genetics , Homozygote , Membrane Glycoproteins/genetics , Membrane Glycoproteins/metabolism , Mutation, Missense , Receptors, Immunologic/genetics , Receptors, Immunologic/metabolismABSTRACT
Porous molecular solids are promising materials for gas storage and gas separation applications. However, given the relative dearth of structural information concerning these materials, additional studies are vital for further understanding their properties and developing design parameters for their optimization. Here, we examine a series of isostructural cuboctahedral, paddlewheel-based coordination cages, M24(tBu-bdc)24 (M = Cr, Mo, Ru; tBu-bdc2- = 5-tert-butylisophthalate), for high-pressure methane storage. As the decrease in crystallinity upon activation of these porous molecular materials precludes diffraction studies, we turn to a related class of pillared coordination cage-based metal-organic frameworks, M24(Me-bdc)24(dabco)6 (M = Fe, Co; Me-bdc2- = 5-methylisophthalate; dabco = 1,4-diazabicyclo[2.2.2]octane) for neutron diffraction studies. The five porous materials display BET surface areas from 1057-1937 m2/g and total methane uptake capacities of up to 143 cm3(STP)/cm3. Both the porous cages and cage-based frameworks display methane adsorption enthalpies of -15 to -22 kJ/mol. Also supported by molecular modeling, neutron diffraction studies indicate that the triangular windows of the cage are favorable methane adsorption sites with CD4-arene interactions between 3.7 and 4.1 Å. At both low and high loadings, two additional methane adsorption sites on the exterior surface of the cage are apparent for a total of 56 adsorption sites per cage. These results show that M24L24 cages are competent gas storage materials and further adsorption sites may be optimized by judicious ligand functionalization to control extracage pore space.
ABSTRACT
Parkinson's disease (PD) is a debilitating neurodegenerative disorder and its rising global incidence highlights the need for the identification of modifiable risk factors. In a gene-based burden test of rare variants (8647 PD cases and 777,693 controls) we discovered a novel association between loss-of-function variants in ITSN1 and PD. This association was further supported with burden data from the Neurodegenerative Disease Knowledge Portal and the Accelerating Medicines Partnership Parkinson's Disease Knowledge Platform. Our findings show that Rho GTPases and disruptions in synaptic vesicle transport may be involved in the pathogenesis of PD, pointing to the possibility of novel therapeutic approaches.
ABSTRACT
Age at menopause (AOM) has a substantial impact on fertility and disease risk. While many loci with variants that associate with AOM have been identified through genome-wide association studies (GWAS) under an additive model, other genetic models are rarely considered1. Here through GWAS meta-analysis under the recessive model of 174,329 postmenopausal women from Iceland, Denmark, the United Kingdom (UK; UK Biobank) and Norway, we study low-frequency variants with a large effect on AOM. We discovered that women homozygous for the stop-gain variant rs117316434 (A) in CCDC201 (p.(Arg162Ter), minor allele frequency ~1%) reached menopause 9 years earlier than other women (P = 1.3 × 10-15). The genotype is present in one in 10,000 northern European women and leads to primary ovarian insufficiency in close to half of them. Consequently, homozygotes have fewer children, and the age at last childbirth is 5 years earlier (P = 3.8 × 10-5). The CCDC201 gene was only found in humans in 2022 and is highly expressed in oocytes. Homozygosity for CCDC201 loss-of-function has a substantial impact on female reproductive health, and homozygotes would benefit from reproductive counseling and treatment for symptoms of early menopause.
ABSTRACT
Autoimmune thyroid disease (AITD) is a common autoimmune disease. In a GWAS meta-analysis of 110,945 cases and 1,084,290 controls, 290 sequence variants at 225 loci are associated with AITD. Of these variants, 115 are previously unreported. Multiomics analysis yields 235 candidate genes outside the MHC-region and the findings highlight the importance of genes involved in T-cell regulation. A rare 5'-UTR variant (rs781745126-T, MAF = 0.13% in Iceland) in LAG3 has the largest effect (OR = 3.42, P = 2.2 × 10-16) and generates a novel start codon for an open reading frame upstream of the canonical protein translation initiation site. rs781745126-T reduces mRNA and surface expression of the inhibitory immune checkpoint LAG-3 co-receptor on activated lymphocyte subsets and halves LAG-3 levels in plasma among heterozygotes. All three homozygous carriers of rs781745126-T have AITD, of whom one also has two other T-cell mediated diseases, that is vitiligo and type 1 diabetes. rs781745126-T associates nominally with vitiligo (OR = 5.1, P = 6.5 × 10-3) but not with type 1 diabetes. Thus, the effect of rs781745126-T is akin to drugs that inhibit LAG-3, which unleash immune responses and can have thyroid dysfunction and vitiligo as adverse events. This illustrates how a multiomics approach can reveal potential drug targets and safety concerns.
Subject(s)
Antigens, CD , Codon, Initiator , Genetic Predisposition to Disease , Lymphocyte Activation Gene 3 Protein , Humans , Codon, Initiator/genetics , Antigens, CD/genetics , Antigens, CD/metabolism , Diabetes Mellitus, Type 1/genetics , Diabetes Mellitus, Type 1/immunology , Female , Polymorphism, Single Nucleotide , Vitiligo/genetics , Male , Genome-Wide Association Study , Thyroiditis, Autoimmune/genetics , 5' Untranslated Regions/genetics , Case-Control Studies , Iceland , AdultABSTRACT
We report a multi-ancestry genome-wide association study on liver cirrhosis and its associated endophenotypes, alanine aminotransferase (ALT) and γ-glutamyl transferase. Using data from 12 cohorts, including 18,265 cases with cirrhosis, 1,782,047 controls, up to 1 million individuals with liver function tests and a validation cohort of 21,689 cases and 617,729 controls, we identify and validate 14 risk associations for cirrhosis. Many variants are located near genes involved in hepatic lipid metabolism. One of these, PNPLA3 p.Ile148Met, interacts with alcohol intake, obesity and diabetes on the risk of cirrhosis and hepatocellular carcinoma (HCC). We develop a polygenic risk score that associates with the progression from cirrhosis to HCC. By focusing on prioritized genes from common variant analyses, we find that rare coding variants in GPAM associate with lower ALT, supporting GPAM as a potential target for therapeutic inhibition. In conclusion, this study provides insights into the genetic underpinnings of cirrhosis.
Subject(s)
Genetic Predisposition to Disease , Genome-Wide Association Study , Liver Cirrhosis , Humans , Liver Cirrhosis/genetics , Liver Neoplasms/genetics , Carcinoma, Hepatocellular/genetics , Alanine Transaminase/blood , Polymorphism, Single Nucleotide , Male , Lipase/genetics , Female , gamma-Glutamyltransferase/genetics , Membrane Proteins/genetics , Cohort Studies , Case-Control Studies , Multifactorial Inheritance/genetics , Risk Factors , Genetic VariationABSTRACT
Importance: Recurrent pericarditis is a treatment challenge and often a debilitating condition. Drugs inhibiting interleukin 1 cytokines are a promising new treatment option, but their use is based on scarce biological evidence and clinical trials of modest sizes, and the contributions of innate and adaptive immune processes to the pathophysiology are incompletely understood. Objective: To use human genomics, transcriptomics, and proteomics to shed light on the pathogenesis of pericarditis. Design, Setting, and Participants: This was a meta-analysis of genome-wide association studies of pericarditis from 5 countries. Associations were examined between the pericarditis-associated variants and pericarditis subtypes (including recurrent pericarditis) and secondary phenotypes. To explore mechanisms, associations with messenger RNA expression (cis-eQTL), plasma protein levels (pQTL), and CpG methylation of DNA (ASM-QTL) were assessed. Data from Iceland (deCODE genetics, 1983-2020), Denmark (Copenhagen Hospital Biobank/Danish Blood Donor Study, 1977-2022), the UK (UK Biobank, 1953-2021), the US (Intermountain, 1996-2022), and Finland (FinnGen, 1970-2022) were included. Data were analyzed from September 2022 to August 2023. Exposure: Genotype. Main Outcomes and Measures: Pericarditis. Results: In this genome-wide association study of 4894 individuals with pericarditis (mean [SD] age at diagnosis, 51.4 [17.9] years, 2734 [67.6%] male, excluding the FinnGen cohort), associations were identified with 2 independent common intergenic variants at the interleukin 1 locus on chromosome 2q14. The lead variant was rs12992780 (T) (effect allele frequency [EAF], 31%-40%; odds ratio [OR], 0.83; 95% CI, 0.79-0.87; P = 6.67 × 10-16), downstream of IL1B and the secondary variant rs7575402 (A or T) (EAF, 45%-55%; adjusted OR, 0.89; 95% CI, 0.85-0.93; adjusted P = 9.6 × 10-8). The lead variant rs12992780 had a smaller odds ratio for recurrent pericarditis (0.76) than the acute form (0.86) (P for heterogeneity = .03) and rs7575402 was associated with CpG methylation overlapping binding sites of 4 transcription factors known to regulate interleukin 1 production: PU.1 (encoded by SPI1), STAT1, STAT3, and CCAAT/enhancer-binding protein ß (encoded by CEBPB). Conclusions and Relevance: This study found an association between pericarditis and 2 independent sequence variants at the interleukin 1 gene locus. This finding has the potential to contribute to development of more targeted and personalized therapy of pericarditis with interleukin 1-blocking drugs.
Subject(s)
Genome-Wide Association Study , Humans , Male , Adolescent , Female , Genotype , Phenotype , Gene Frequency , FinlandABSTRACT
Metal-organic frameworks (MOFs), tunable, nanoporous materials, are alluring recognition elements for gas sensing. Mimicking human olfaction, an array of cross-sensitive, MOF-based sensors could enable analyte detection in complex, variable gas mixtures containing confounding gas species. Herein, we address the question: given a set of MOF candidates and their adsorption properties, how do we select the optimal subset to compose a sensor array that accurately and robustly predicts the gas composition via monitoring the adsorbed mass in each MOF? We first mathematically formulate the MOF-based sensor array problem under dilute conditions. Instructively, the sensor array can be viewed as a linear map from gas composition space to sensor array response space defined by the matrix H of Henry coefficients of the gases in the MOFs. Characterizing this mapping, the singular value decomposition of H is a useful tool for evaluating MOF subsets for sensor arrays, as it determines the sensitivity of the predicted gas composition to measurement error, quantifies the magnitude of the response to changes in composition, and recovers which direction in gas composition space elicits the largest/smallest response. To illustrate, on the basis of experimental adsorption data, we curate MOFs for a sensor array with the objective of determining the concentration of CO2 and SO2 in the gas phase.
ABSTRACT
Metal-organic frameworks (MOFs) are highly tuneable, extended-network, crystalline, nanoporous materials with applications in gas storage, separations, and sensing. We review how molecular models and simulations of gas adsorption in MOFs have informed the discovery of performant MOFs for methane, hydrogen, and oxygen storage, xenon, carbon dioxide, and chemical warfare agent capture, and xylene enrichment. Particularly, we highlight how large, open databases of MOF crystal structures, post-processed to enable molecular simulations, are a platform for computational materials discovery. We discuss how to orient research efforts to routinise the computational discovery of MOFs for adsorption-based engineering applications.
ABSTRACT
Porous organic cage molecules harbor nanosized cavities that can selectively adsorb gas molecules, lending them applications in separations and sensing. The geometry of the cavity strongly influences their adsorptive selectivity. For comparing cages and predicting their adsorption properties, we embed/encode a set of 74 porous organic cage molecules into a low-dimensional, latent "cage space" on the basis of their intrinsic porosity. We first computationally scan each cage to generate a three-dimensional (3D) image of its porosity. Leveraging the singular value decomposition, in an unsupervised manner, we then learn across all cages an approximate, lower-dimensional subspace in which the 3D porosity images congregate. The "eigencages" are the set of orthogonal, characteristic 3D porosity images that span this lower-dimensional subspace, ordered in terms of importance. A latent representation/encoding of each cage follows by approximately expressing it as a combination of the eigencages. We show that the learned encoding captures salient features of the cavities of porous cages and is predictive of properties of the cages that arise from cavity shape. Our methods could be applied to learn latent representations of cavities within other classes of porous materials and of shapes of molecules in general.